Cargando…

Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss

Vestibular schwannoma is the most common benign neoplasm of the cerebellopontine angle. It arises from Schwann cells of the vestibular nerve. The first symptoms of vestibular schwannoma include hearing loss, tinnitus, and vestibular symptoms. In the event of further growth, cerebellar and brainstem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesařová, Michaela, Peterková, Lenka, Šťastná, Monika, Kolář, Michal, Lacina, Lukáš, Smetana, Karel, Hynek, Radovan, Betka, Jan, Vlasák, Aleš, Lukeš, Petr, Fík, Zdeněk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856152/
https://www.ncbi.nlm.nih.gov/pubmed/36672540
http://dx.doi.org/10.3390/biomedicines11010032
_version_ 1784873553595727872
author Tesařová, Michaela
Peterková, Lenka
Šťastná, Monika
Kolář, Michal
Lacina, Lukáš
Smetana, Karel
Hynek, Radovan
Betka, Jan
Vlasák, Aleš
Lukeš, Petr
Fík, Zdeněk
author_facet Tesařová, Michaela
Peterková, Lenka
Šťastná, Monika
Kolář, Michal
Lacina, Lukáš
Smetana, Karel
Hynek, Radovan
Betka, Jan
Vlasák, Aleš
Lukeš, Petr
Fík, Zdeněk
author_sort Tesařová, Michaela
collection PubMed
description Vestibular schwannoma is the most common benign neoplasm of the cerebellopontine angle. It arises from Schwann cells of the vestibular nerve. The first symptoms of vestibular schwannoma include hearing loss, tinnitus, and vestibular symptoms. In the event of further growth, cerebellar and brainstem symptoms, along with palsy of the adjacent cranial nerves, may be present. Although hearing impairment is present in 95% of patients diagnosed with vestibular schwannoma, most tumors do not progress in size or have low growth rates. However, the clinical picture has unpredictable dynamics, and there are currently no reliable predictors of the tumor’s behavior. The etiology of the hearing loss in patients with vestibular schwannoma is unclear. Given the presence of hearing loss in patients with non-growing tumors, a purely mechanistic approach is insufficient. A possible explanation for this may be that the function of the auditory system may be affected by the paracrine activity of the tumor. Moreover, initiation of the development and growth progression of vestibular schwannomas is not yet clearly understood. Biallelic loss of the NF2 gene does not explain the occurrence in all patients; therefore, detection of gene expression abnormalities in cases of progressive growth is required. As in other areas of cancer research, the tumor microenvironment is coming to the forefront, also in vestibular schwannomas. In the paradigm of the tumor microenvironment, the stroma of the tumor actively influences the tumor’s behavior. However, research in the area of vestibular schwannomas is at an early stage. Thus, knowledge of the molecular mechanisms of tumorigenesis and interactions between cells present within the tumor is crucial for the diagnosis, prediction of tumor behavior, and targeted therapeutic interventions. In this review, we provide an overview of the current knowledge in the field of molecular biology and tumor microenvironment of vestibular schwannomas, as well as their relationship to tumor growth and hearing loss.
format Online
Article
Text
id pubmed-9856152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98561522023-01-21 Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss Tesařová, Michaela Peterková, Lenka Šťastná, Monika Kolář, Michal Lacina, Lukáš Smetana, Karel Hynek, Radovan Betka, Jan Vlasák, Aleš Lukeš, Petr Fík, Zdeněk Biomedicines Review Vestibular schwannoma is the most common benign neoplasm of the cerebellopontine angle. It arises from Schwann cells of the vestibular nerve. The first symptoms of vestibular schwannoma include hearing loss, tinnitus, and vestibular symptoms. In the event of further growth, cerebellar and brainstem symptoms, along with palsy of the adjacent cranial nerves, may be present. Although hearing impairment is present in 95% of patients diagnosed with vestibular schwannoma, most tumors do not progress in size or have low growth rates. However, the clinical picture has unpredictable dynamics, and there are currently no reliable predictors of the tumor’s behavior. The etiology of the hearing loss in patients with vestibular schwannoma is unclear. Given the presence of hearing loss in patients with non-growing tumors, a purely mechanistic approach is insufficient. A possible explanation for this may be that the function of the auditory system may be affected by the paracrine activity of the tumor. Moreover, initiation of the development and growth progression of vestibular schwannomas is not yet clearly understood. Biallelic loss of the NF2 gene does not explain the occurrence in all patients; therefore, detection of gene expression abnormalities in cases of progressive growth is required. As in other areas of cancer research, the tumor microenvironment is coming to the forefront, also in vestibular schwannomas. In the paradigm of the tumor microenvironment, the stroma of the tumor actively influences the tumor’s behavior. However, research in the area of vestibular schwannomas is at an early stage. Thus, knowledge of the molecular mechanisms of tumorigenesis and interactions between cells present within the tumor is crucial for the diagnosis, prediction of tumor behavior, and targeted therapeutic interventions. In this review, we provide an overview of the current knowledge in the field of molecular biology and tumor microenvironment of vestibular schwannomas, as well as their relationship to tumor growth and hearing loss. MDPI 2022-12-23 /pmc/articles/PMC9856152/ /pubmed/36672540 http://dx.doi.org/10.3390/biomedicines11010032 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tesařová, Michaela
Peterková, Lenka
Šťastná, Monika
Kolář, Michal
Lacina, Lukáš
Smetana, Karel
Hynek, Radovan
Betka, Jan
Vlasák, Aleš
Lukeš, Petr
Fík, Zdeněk
Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title_full Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title_fullStr Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title_full_unstemmed Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title_short Tumor Biology and Microenvironment of Vestibular Schwannoma-Relation to Tumor Growth and Hearing Loss
title_sort tumor biology and microenvironment of vestibular schwannoma-relation to tumor growth and hearing loss
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856152/
https://www.ncbi.nlm.nih.gov/pubmed/36672540
http://dx.doi.org/10.3390/biomedicines11010032
work_keys_str_mv AT tesarovamichaela tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT peterkovalenka tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT stastnamonika tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT kolarmichal tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT lacinalukas tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT smetanakarel tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT hynekradovan tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT betkajan tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT vlasakales tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT lukespetr tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss
AT fikzdenek tumorbiologyandmicroenvironmentofvestibularschwannomarelationtotumorgrowthandhearingloss